ipilimumab
bms
['ipilimumab', 'sarcoma']
today at 12:30 edt, matthew ingham, md, will showcase results from a study of int230-6, both as a monotherapy and in combination with ipilimumab (ipi), across a broad spectrum of refractory soft tissue sarcomas. #asco22 more info: 
Updates on innovations in #cancer research, prevention, care, and education from the Herbert Irving Comprehensive Cancer Center at @columbiamed/@nyphospital.